Company Filing History:
Years Active: 2007-2012
Title: Alan Olague: Innovator in Cancer and Diabetes Treatment
Introduction
Alan Olague is a notable inventor based in Shelton, CT (US), recognized for his contributions to the fields of cancer and diabetes treatment. With a total of 3 patents, Olague has made significant strides in developing novel compounds aimed at addressing critical health issues.
Latest Patents
One of his latest patents is focused on pyrrolotriazine derivatives that are useful for treating cancer through the inhibition of aurora kinase. This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly cancer. Another significant patent involves heteroarylaminopyrazole derivatives that are useful for the treatment of diabetes. This invention encompasses heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
Career Highlights
Throughout his career, Alan Olague has worked with prominent organizations, including Bayer Pharmaceuticals Corporation. His work in these companies has allowed him to contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Olague has collaborated with esteemed colleagues such as Steven R. Magnuson and Joachim Rudolph, further enhancing the impact of his work in the medical field.
Conclusion
Alan Olague's innovative contributions to cancer and diabetes treatment through his patents highlight his dedication to improving healthcare. His work continues to inspire advancements in pharmaceutical research and development.